Bay Colony Advisors’s GSK GSK Stock Holding History

Bay Colony Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,238	Closed	-$294K	–	361
2023 Q2	$294K	Buy	8,238 +22	+0.3%	+$789	0.07%	241
2023 Q1	$290K	Buy	8,216 +403	+5%	+$14.1K	0.08%	235
2022 Q4	$275K	Buy	+7,813	New	+$260K	0.07%	265
2021 Q3	–	Sell	-10,578	Closed	-$527K	–	358
2021 Q2	$527K	Sell	10,578 -30	-0.3%	-$1.44K	0.18%	160
2021 Q1	$473K	Sell	10,608 -142	-1%	-$6.45K	0.18%	157
2020 Q4	$494K	Buy	10,750 +380	+4%	+$17.5K	0.26%	118
2020 Q3	$488K	Buy	10,370 +4,138	+66%	+$207K	0.3%	99
2020 Q2	$318K	Buy	+6,232	New	+$320K	0.23%	128
2020 Q1	–	Sell	-8,268	Closed	-$494K	–	202
2019 Q4	$494K	Buy	8,268 +2,030	+33%	+$113K	0.32%	110
2019 Q3	$333K	Buy	6,238 +1,220	+24%	+$62.8K	0.23%	160
2019 Q2	$251K	Buy	5,018 +894	+22%	+$44.9K	0.16%	175
2019 Q1	$216K	Buy	+4,124	New	+$206K	0.14%	187
2018 Q3	–	Sell	-2,662	Closed	-$134K	–	473
2018 Q2	$134K	Buy	+2,662	New	+$134K	0.09%	200

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bay Colony Advisors's GSK Position: Q3 2023 in Review

Bay Colony Advisors sold out of GSK (GSK) in Q3 2023, closing a stake of 8,238 shares — an estimated $294K sold.

Bay Colony Advisors first reported a position in GSK in Q2 2018 and held it in 13 quarters. The position peaked at $527K in Q2 2021. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Bay Colony Advisors reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Bay Colony Advisors sold 8,238 GSK shares in Q3 2023, an estimated $294K.
Bay Colony Advisors first reported a position in GSK in Q2 2018 and held it in 13 quarters.
Bay Colony Advisors's GSK position peaked at $527K in Q2 2021.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Bay Colony Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.